Layla Hosseini-Gerami is a Co-Founder and Chief Data Science Officer at Ignota Labs who applies an interdisciplinary blend of chemistry, bioinformatics and AI to rescue failing drugs and prevent adverse reactions. With a PhD from the University of Cambridge and an award-winning thesis on integrative cheminformatics and bioinformatics, she has translated academic methods into industry collaborations, including work with Eli Lilly. Over eight years she has built predictive frameworks to uncover molecular mechanisms of toxicity and guide mitigation strategies, earning recognition such as Innovate UK Women in Innovation and Forbes 30 Under 30. Notably, her early work produced a pKa model now used in commercial software, reflecting a practical focus on turning computational insight into deployed tools. Based in Cambridge, she balances deep domain expertise with entrepreneurial drive to improve patient outcomes by making AI both explanatory and preventative.
7 years of coding experience
Doctor of Philosophy - PhD, Chemistry - Bioinformatics, Doctor of Philosophy - PhD, Chemistry - Bioinformatics at University of Cambridge
Master’s Degree, MChem/BSc Chemistry, Master’s Degree, MChem/BSc Chemistry at University of Leeds
High School, Sciences + Maths, High School, Sciences + Maths at Aylesbury High School
Elucidate and visualise a compound's mechanism of action by combining structure-based target prediction with gene expression-based causal reasoning, plus pathway enrichment to put results into biological context. GUI-based (minimal coding experience required).
Contributions:2 releases, 240 commits, 6 PRs in 2 years 3 months
pidgingui-basedelucidatecausaldorothea
Find and Hire Top DevelopersWe’ve analyzed the programming source code of over 60 million software developers on GitHub and scored them by 50,000 skills. Sign-up on Prog,AI to search for software developers.